Dr. Dominik Witzigmann
Office room number 2007
Dominik Witzigmann graduated in Pharmacy at the University of Freiburg, Germany. After an interdisciplinary research project at the University College London he obtained his license as pharmacist in 2011. He continued as a research assistant in the Division of «Molecular RNA Biology and Cancer» at the German Cancer Research Center (DKFZ) on «RNAi and Cancer».
In September 2012 Dominik joined the research division «Pharmaceutical Technology» of Prof. Dr. Huwyler at the University of Basel. His research is focused on strategies to improve organ and cell type-specific drug delivery of nanoparticles. In April 2016, Dominik successfully defended his PhD thesis on «Hepatocyte-specific drug delivery using active targeted nanomedicines - evaluation of targeting strategies in vitro and in vivo».
His current projects are focused on nanomedicines for improved delivery of nucleic acids.
For more information:
|Uhl, Philipp; Pantze, Silvia; Storck, Philip; Parmentier, Johannes; Witzigmann, Dominik; Hofhaus, Götz; Huwyler, Jörg; Mier, Walter; Fricker, Gert: Oral delivery of vancomycin by tetraether lipid liposomes, in: European Journal of Pharmaceutical Sciences 108, 2017, S. 111-118. edoc|
|Kiene, Klara; Schenk, Susanne H.; Porta, Fabiola; Ernst, Alexandra; Witzigmann, Dominik; Grossen, Philip; Huwyler, Jörg: PDMS-b-PMOXA polymersomes for hepatocyte targeting and assessment of toxicity, in: European journal of pharmaceutics and biopharmaceutics 119, 2017, S. 322-332. URL|
|Grossen, Philip; Witzigmann, Dominik; Sieber, Sandro; Huwyler, Jörg: PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application, in: Journal of Controlled Release, 2017, S. 46-60. URL|